Saharan et al.
Dissolution Enhancement of Drugs
Reprinted from
International Journal
Health Research
Peer-reviewed Online Journal
http://www.ijhr.org
Abstracting/Indexing
African Index Medicus, Open-J-Gate, Directory of Open Access Journals (DOAJ), Socolar,
EBSCO, Index Corpenicus, Embase
Int J Health Res, June 2009; 2(2): 105
Saharan et al.
Dissolution Enhancement of Drugs
International Journal of Health Research
The International Journal of Health Research is an online international journal allowing free unlimited access to
abstract and full-text of published articles. The journal is devoted to the promotion of health sciences and related
disciplines (including medicine, pharmacy, nursing, biotechnology, cell and molecular biology, and related
engineering fields). It seeks particularly (but not exclusively) to encourage multidisciplinary research and
collaboration among scientists, the industry and the healthcare professionals. It will also provide an international
forum for the communication and evaluation of data, methods and findings in health sciences and related
disciplines. The journal welcomes original research papers, reviews and case reports on current topics of special
interest and relevance. All manuscripts will be subject to rapid peer review. Those of high quality (not previously
published and not under consideration for publication) will be published without delay. The maximum length of
manuscripts should normally be 10,000 words (20 single-spaced typewritten pages) for review, 6,000 words for
research articles, 3,000 for technical notes, case reports, commentaries and short communications.
Submission of Manuscript: The International Journal of Health Research uses a journal management
software to allow authors track the changes to their submission. All manuscripts must be in MS Word and in
English and should be submitted online at http://www.ijhr.org. Authors who do not want to submit online or
cannot submit online should send their manuscript by e-mail attachment (in single file) to the editorial office
below. Submission of a manuscript is an indication that the content has not been published or under consideration for
publication elsewhere. Authors may submit the names of expert reviewers or those they do not want to review their papers.
The Editorial Office
International Journal of Health Research
Dean’s Office, College of Medicine
Madonna University, Elele Campus, Rivers State
E-mail: editor_ijhr@yahoo.com or editor@ijhr.org
Academic Publishers
Int J Health Res, June 2009; 2(2): 106
Saharan et al.
Dissolution Enhancement of Drugs
International Journal of Health Research, June 2009; 2(2): 107-124 (e222p3-20)
© Poracom Academic Publishers. All rights reserved
.
Available at http://www.ijhr.org
Review Article
Online Journal
Dissolution Enhancement of Drugs.
Part I: Technologies and Effect of Carriers
Received: 03-Dec-08
Revised: 12-Apr-09
Accepted: 05-May-09
Abstract
For complete absorption and good bioavailability of orally
administered drug, the drug must be dissolved in gastric
fluids. Dissolution of drug is the rate-controlling step which
determines the rate and degree of absorption. Drugs with
slow dissolution rates generally show erratic and incomplete
absorption leading to low bioavailability when administered
orally. Since aqueous solubility and slow dissolution rate of
BCS class II and class IV drugs is a major challenge in the
drug development and delivery processes, improving
aqueous solubility and slow dissolution of BCS Class II and
Class IV drugs have been investigated extensively. Various
techniques have been used in attempt to improve solubility
and dissolution rates of poorly water soluble drugs which
include solid dispersion, micronization, lipid based
formulations, melt granulation, direct compaction, solvent
evaporation, coprecipitation, adsorption, ordered mixing,
liquisolid compacts, solvent deposition inclusion complexation
and steam aided granulation. In these techniques carrier
plays an important role in improving solubility and dissolution
rate.
Polymers,
superdisintegrants,
surfactants
are
extensively studied in recent years for dissolution
enhancement in drugs. This part of this review discusses
technological
overview
and
effect
of
polymers,
superdisintegrants
and
surfactants
on
dissolution
enhancement of drugs while Part II [Int J Health Res, Sept
2009; 2(3)] describes the role and applications of
cyclodextrins, carbohydrates, hydrotropes, polyglocolized
glycerides, dendrimers, acids and miscellaneous carriers in
enhancing dissolution of drugs.
Keywords: Dissolution enhancement; aqueous solubility,
water soluble carriers; BCS class II, excipients.
e222p3
Vikas A Saharan1
Vipin Kukkar1
Mahesh Kataria1
Manoj Gera1
Pratim K Choudhury2
1
Institute
of
Pharmaceutical
Sciences and Drug Research, Seth
GL Bihani SD College of Technical
Education,
Sri
Ganganagar,
Rajasthan, India
2
Department of Pharmaceutical
Sciences, ML Sukhadia University,
Udaipur, Rajasthan, India
For Correspondence:
Vikas A Saharan, Assistant
Professor and In charge,
Committee for Higher Education
Guidance (GATE Cell), Seth G. L.
Bihani S. D. College of Technical
Education, Gaganpath, Sri
Ganganagar, Rajasthan, India.
Mobile: +91-9799299706
Tel: +91-154-2466777
Fax: +91-154-2466774
Email:
vikas.pharmaceutics@gmail.com
Int J Health Res, June 2009; 2(2): 107
Saharan et al.
Introduction
Nearly one-third of drugs in development are
water insoluble and one-half fail in trials
because of underprivileged pharmacokinetics [1]. These poorly water soluble drugs
are allied with slow drug absorption leading
to inadequate and variable bioavailability and
G.I. mucosal toxicity of drugs [2]. Poorly
water soluble drugs belong to BCS class II
and Class IV [3] group of compounds. In the
process of absorption of drug from oral route
dissolution is the rate limiting step for
lipophilic drugs. Therefore it is necessary to
enhance dissolution of these drugs to ensure
maximum therapeutic utility of these drugs.
Before studying the various approaches to
enhance dissolution it is necessary to
understand the basic process of dissolution.
Dissolution is a process by which a solid
substance goes into solution. The extent to
which the dissolution proceeds, under a
given set of conditions is referred to as the
solubility of the substance in the solvent i.e.
rate of solution (dissolution) and amount that
can be dissolved (solubility) are not same.
The dissolution rate of a drug is directly
proportional to its solubility as per NoyesWhitney equation and therefore solubility of a
drug substance is a major factor that
determines its dissolution rate and hence its
absorption and bioavailability eventually [4].
The various properties of drug that affect
drug dissolution and its rate includes
solubility, particle size, polymorphism, salt
form, complexation, wettability, etc [5] and
can be targeted to enhance dissolution of
poorly water soluble drugs. Use of water
soluble excipients is common and simplest
way to enhance dissolution rate of
hydrophobic drugs. These excipients namely
polymers, superdisintegrants, carbohydrates,
surfactants hydrotropes, acids etc work in
different ways to enhance water solubility of
drugs. The role of techniques of preparation
of formulation is as imperative as the choice
of the carriers to enhance dissolution of
drugs due to difference in reduction of
crystallinity of the product and surface
e222p4
Dissolution Enhancement of Drugs
characteristics of the particles. Part I of this
review
highlights
various
dissolution
enhancement techniques for poorly water
soluble drugs as well as role of few water
soluble
carriers,
viz.
polymers,
superdisintegrants and surfactants, in
dissolution enhancement. While part II [Int J
Health Res, Sept 2009; 2(3)] describes use
of cyclodextrins, carbohydrates, hydrotropes,
polyglocolized glycerides, dendrimers, acids
and miscellaneous carriers in enhancing
dissolution of drugs.
Techniques for Dissolution Enhancement
There are several techniques reported in
literature for formulation of hydrophobic
drugs with enhanced dissolution rate. These
techniques are carefully selected on the
basis of properties of drug, excipients and
dosage forms.
Solid Dispersion
Solid dispersion is defined as a dispersion of
one or more active ingredients in an inert
carrier or matrix at solid state prepared by
the melting (fusion), solvent, or meltingsolvent method [6]. In melting method carrier
is melted and drug is added with stirring and
melted until homogenous melt is obtained
which is then cooled to room temperature
while in solvent method drug and carrier is
dissolved in minimum amount of solvent and
solvent is removed by evaporation under
reduced pressure [7]. Solid dispersions are
also prepared by dissolving drug and carrier
in a common solvent followed by evaporation
of the solvent. Melting-solvent method
involves use of heating and solvent action to
dissolve the drug and carrier in solvent
followed by evaporation of the solvent. Solid
dispersion technique improves the solubility,
dissolution rate, and as a result the
bioavailability of poorly water-soluble drugs
[8].
Int J Health Res, June 2009; 2(2): 108
Saharan et al.
The higher dissolution rates of solid
dispersions can be ascribed to a number of
factors which includes:
Dissolution Enhancement of Drugs
Solid inclusion complexes can be prepared
by using following methods:
a) Kneading Technique
1. The formation of higher energy
metastable states of the components as
a function of the carrier system being
used and the proportion of carriers
present [9].
2. The reduction of particle size to nearly a
molecular level [10]. As the soluble
carrier dissolves, the insoluble drug is
exposed to dissolution medium as very
fine particles leading to an increase in
both surface area and solubilization for
fast dissolution and absorption [6].
3. Formation of amorphous forms of drug
and carriers [11].
4. The presence of carrier may also prevent
aggregation of fine drug particles,
thereby providing a larger surface area
for dissolution. The wetting properties
are also greatly increased due to the
surfactant property of the polymer,
resulting in decreased interfacial tension
between the medium and the drug,
hence higher dissolution rates. The
presence of carrier polymers also inhibits
crystal growth of the drug which
facilitates faster dissolution [9].
5. Cosolvent effect on the drug by the water
soluble carriers [11].
6. Intermolecular hydrogen bonds between
drug and carrier [12].
7. Local solubilization effect of carrier at the
diffusion layer [7].
In this technique, cyclodextrin (CD) is
impregnated with water and converted to
paste. Drug is then added and kneaded for
specified time. The kneaded mixture is then
dried and passed through sieve if required
[14].
b) Coprecipitation
Required amount of drug is added to the
solution of -CD. The system is kept under
magnetic agitation with controlled process
parameters and protected from the light. The
formed precipitate is separated by vacuum
filtration and dried at room temperature in
order to avoid the loss of the structure water
from the inclusion complex [15].
c) Neutralization
Drug is added in alkaline solution like sodium
hydroxide, ammonium hydroxide. A solution
of β- Cyclodextrin is then added to dissolve
the joined drug. The clear solution obtained
after few seconds under agitation is
neutralized using HCl solution until reaching
the equivalence point. At this moment, the
appearance of a white precipitate could be
appreciated, corresponding to the formation
of the inclusion compound. The precipitate is
then filtered and dried [16].
d) Co-grinding
Various factors affecting dissolution of drug
from solid dispersion includes the method of
preparation of the solid dispersion, amount
and properties of the polymer carriers, drug
polymer
contact
and
drug-polymer
interactions [13].
Drug and cyclodextrin are mixed and the
physical mixture is introduced in a suitable
mill like oscillatory mill and grinded for
suitable time [15].
Inclusion Complexation
Drug is dissolved in suitable solvent and the
required stoichiometric amount of carrier
material like
cyclodextrin is dissolved in
water. Solutions are then mixed by
sonication or other suitable method to
This is most widely used method to enhance
water solubility and increase stability of
hydrophobic drugs by using cyclodextrins.
e222p5
e) Spray-Drying Method
Int J Health Res, June 2009; 2(2): 109
Saharan et al.
produce a clear solution, which is then spraydried using spray dryer [15].
f)
Microwave Irradiation Method
Drug and cyclodextrins mixture is reacted in
microwave oven to form inclusion. It is a
novel method for industrial scale preparation
due to its major advantage of shorter
reaction time and higher yield of product [17].
Steam-Aided Granulation
Steam instead of water can be used in wet
granulation because it provides a higher
diffusion rate into the powder and a more
favorable thermal balance during the drying
step. After condensation of the steam, water
forms a hot thin film, requiring only a small
amount of extra energy for its elimination and
evaporates more easily. The use of steam
instead of liquid water in a wet granulation
method can considerably decrease the
amount of water used and as a result the
whole operational time [18].
Cogrinding / Comicronization
Cogrinding of a poorly water-soluble drug
with
water-soluble
polymers
like
hydroxypropyl methylcellulose (HPMC), poly
vinyl alcohol (PVA) etc in the presence of
small amount of water is extremely effective
to improve its apparent solubility with
maintenance of drug crystallinity to some
extent [19]. Small particles produced by
milling or micronization have increased
surface area and expected to have
enhanced dissolution rate. However, energy
added to reduce particle size results in
increased van der Waal’s interactions and
electrostatic attraction between particles
leading to reduce effective surface area due
to agglomeration thus decreasing dissolution
rate. Comicronization of drugs by using
excipients like microcrystalline cellulose can
be used as an alternative to reduce or
eliminate cohesive and electrostatic forces.
This approach increases apparent surface
area available for drug dissolution by
creating an ordered mixture, thereby causing
e222p6
Dissolution Enhancement of Drugs
a reduction in particle-particle agglomeration
or by reducing van der Waal’s interactions.
Increase in true surface area of the ordered
powdered mixture is expected due to the
inherent surface roughness and porosity of
the microcrystalline cellulose-drug mixture
[20].
Lipid-based formulations
Lipid-based delivery systems like emulsions,
microemulsions, liposomes, microspheres,
solid-lipid nanoparticles, etc have ability to
avoid resistant chemical and physical
barriers to oral absorption and are most
successful in enhancing the bioavailability of
molecules that are poorly water-soluble but
highly permeable drug molecules (BCS class
II). Some proposed mechanisms of action of
lipid-based systems to enhance oral
bioavailability of compounds include [21]:
a) Particle size reduction to molecular size
yielding a solid-state solution within the
carrier.
b) Enhanced wetting of hydrophobic solids
resulting in enhanced dissolution.
c) Increased rate of dissolution into
aqueous environment from oil droplets of
high surface area.
d) Promotion of absorption via intrinsic lipid
pathways.
e) Enhanced thermodynamic activity via
supersaturation
of
the
aqueous
environment of the gastrointestinal tract.
Melt-Granulation
In this technique powdered drugs are
efficiently agglomerated by the use of a
meltable binder which can be a molten liquid,
a solid or a solid that melts during the
process usually in high shear mixers, where
the product temperature is raised higher than
the melting point of the binder either by a
heating jacket or, when the impeller speed is
high enough, by the heat of friction
generated by the impeller blades [22]. In this
technique no water or organic solvents are
Int J Health Res, June 2009; 2(2): 110
Saharan et al.
Dissolution Enhancement of Drugs
needed and there is no drying step therefore
the process is environmentally safe, less
time consuming and uses less energy than
conventional
wet
granulation
[23].
Polyethylene glycol is widely used as a
molten binder due to its complimentary
solution properties, low melting point, rapid
solidification rate, low toxicity and little cost
[22]. The increase in dissolution rate can be
ascribed to the hydrophilic character of the
system due to the presence of water-soluble
carriers and the fact that the drug forms
monotectic mixtures with PEG [23].
Direct Compaction
In this process polymer like hydroxypropyl
methylcellulose and drug is dry-blended,
compressed into slugs and then milled into a
granular powder. The process results in
enhanced dissolution rate of poorly watersoluble drugs without the use of solvent or
heat addition to overcome the disadvantages
of solid dispersion by these methods. This
process is also cost effective and quicker.
The compaction processes are believed to
be particularly effective at enhancing the rate
of drug dissolution because the drug
particles are maintained in direct contact with
the polymer particles during drug dissolution,
in contrast with a physical mixture where the
drug and polymer particles may rapidly
disperse and be separated in the dissolution
medium [24].
Solvent Evaporation
Freezing (URF)
by
Ultra-Rapid
This process involves freezing a drug
contained in a polymer solution onto the
surface of a cryogenic substrate with a
thermal conductivity (k) between 10 and 20
W/(m K), collecting the frozen particles and
removing the solvent. Because of rapid
conductive heat transfer, resulting in high
supersaturation and nucleation rates, the
URF technology has the potential to create
powders with superior physicochemical
properties, similar to those produced by
other rapid freezing technologies. As in other
freezing technologies, the rapid freezing of
e222p7
the drug/polymer composition is decisive in
preventing phase separation during freezing,
allowing for the active to be molecularly
dispersed with the polymer. Recrystallization
of the drug is avoided by the inclusion of high
glass-transition temperature (Tg) polymers
such as PVP or hypromellose (HPMC). This
technique is widely applicable to enhance invivo absorption for the BCS class II
compounds [25].
Coevaporate System / Coprecipitation
Weak basic drugs like prochlorperazine
maleate contain good solubility in acidic pH
but in alkaline pH solubility is significantly
reduced
and
when
a
conventional
formulation containing weak base is given
orally precipitation of poorly soluble free
base occurs within formulation in intestinal
fluid. Precipitated drug is no longer capable
of release from formulation leading to
decrease in bioavailability of drug. This
problem can be solved by use of
coevaporate system which incorporates a
carrier with solubilizing effect in alkaline
intestinal fluid which may operate in the
microenvironment, immediately surrounding
the drug particle and polymers for controlling
the dissolution rate to formulate dosage
forms ensuring maximum bioavailability with
controlled release of weak base [26].
Ordered/Interactive Mixing
Ordered mixing is described as method to
prepare ordered units in the mix such that
the ordered unit will be the smallest possible
sample of the mix and will be of near
identical composition to all the other ordered
units in the mix. Ordered mixing yields nearly
the perfect mix and may be obtained in a
number of ways like mechanical means,
adhesion, coating and other methods [27].
Prerequisite for fast dissolution from an
ordered mixture includes that the carrier
particle should dissolve rapidly, delivering a
fine particulate suspension of drug particles
[28]. Higher concentration of drug shows
reduced dissolution rates particularly at
loadings
above
monolayer
coverage
Int J Health Res, June 2009; 2(2): 111
Saharan et al.
because high concentration of drug forms
agglomerates rather than discrete particles
with resulting decreased surface area and
thicker diffusional layers causing reduction in
dissolution rates [29]. In an ordered powder
mix fine drug particles are distributed fairly
evenly on coarse carrier particles. The drug
powder is therefore deagglomerated in the
dry state. This may be used to increase the
dissolution rate of drug powders because a
larger contact surface area is exposed to the
dissolution medium [28].
Adsorption of Drugs onto High Surface
Area Carriers
In this technique drug is absorbed onto
carriers having large surface area (like
crosslinked polyvinylpyrrolidone, Kollidone)
from solutions of the drug in appropriate
solvents like methanol, polyethylene glycol,
and 2-pyrrolidone. The dissolution rate of
drug increases due to increase in surface
area and drug particles have good wettability
due to the surrounding solubilising materials
[30].
Liquisolid Compacts
Liquid Compacts are compressible powdered
forms of liquid medications. The term
“liquisolid medication” implies oily liquid
drugs and solutions or suspensions of waterinsoluble drugs carried in suitable nonvolatile solvent systems. Using this
technique, a liquid medication may be
converted into a dry, non-adherent, free
flowing and compressible powder by a
simple blending with selected powder
excipients such as the carrier and coating
material. Surfactants like tweens are used to
improve aqueous solubility of poorly soluble
drugs [31].
Solvent Deposition / Evaporation
In this technique drug is dissolved in a
solvent like methylene chloride to produce a
clear solution. The carrier is then dispersed
in the solution by stirring and the solvent is
removed by evaporation under temperature
and pressure. The resultant mass is then
e222p8
Dissolution Enhancement of Drugs
dried, pulverized, and passed through a
sieve. The Increase in the dissolution rate is
ascribed to the reduced particle size of the
drug deposited on the carrier and enhanced
wettability of the particles brought about by
the carrier [32].
Carriers for Dissolution Enhancement
Carriers, which are soluble and dissolve in
water at a fast rate, are widely used in
pharmaceutical formulations to enhance
dissolution of drugs. The carriers which have
been reported in literature are presented in
Table 1 and are described in detail under
different categories.
Polymers
Polymers like polyethylene glycols (PEGs),
hydroxypropyl
methylcellulose
(HPMC),
hydroxypropyl
cellulose
(HPC),
polyvinylpyrrolidone (PVP) etc when used in
optimum concentration lead to increase in
dissolution rate due to reduction in particle
size, solubilization effect of the carrier,
increase
wettability and
dispersibility,
formation of hydrogen bonds between drug
and carrier (Table 2). When polymers are
used in higher proportion these can
decrease dissolution rate due to leaching out
of the carrier during dissolution which might
form a concentrated layer of solution around
the drug particles and the migration of the
released drug particles to the bulk of the
dissolution medium slows down [12].
Solid dispersions (SDs) of glyburide were
prepared using PEG 4000, PEG 6000 and a
mixture of PEG 4000 and PEG 6000 (1:1
ratio) by fusion and solvent method and
selected solid dispersions were lyophilized.
The dispersion containing glyburide/PEG
6000, 1:8, showed 14-fold increase in
dissolution and dispersion containing
glyburide/PEG 4000, 1:10, showed an 8-fold
and dispersion containing 6 parts of PEG
mixture show 12-fold increase as compared
with pure drug. Lyophylization of solid
dispersions further supplement dissolution
Int J Health Res, June 2009; 2(2): 112
Saharan et al.
Dissolution Enhancement of Drugs
Table 1: Classification of carriers enhancing dissolution of drugs
S/N
Category
Example of carriers
1.
Polymers
Polyvinylpyrrolidone, Polyvinylpolypyrrolidone,
Polyvinyl alcohol, Polyethylene glycols, Hydroxypropyl
methylcellulose, Hydroxypropyl cellulose, Poly (2hydroxyethylmethacrylate), Methacrylic copolymers (Eudragit®
S100 sodium salts and Eudragit® L100 sodium salts)
2.
Superdisintegrants
Sodium starch glycolate, Croscarmellose sodium,
Cross-linked polyvinylpyrrolidone, Cross-linked alginic acid,
Gellan gum, Xanthan gum, Calcium silicate
3.
Cyclodextrins
4.
Carbohydrates
Lactose, Soluble starch, Sorbitol, Mannitol,
-(1-4)-2-amino-2-deoxy-D-glucose (Chitosan),
Maltose, Galactose, Xylitol, Galactomannan, British gum,
Amylodextrin
5.
Surfactants
Poloxamers (Lutrol® F 127, Lutrol® F 68), Polyglycolized
glyceride (Labrasol), Polyoxyethylene sorbitan monoesters
(Tweens), Sorbitan esters (Spans), Polyoxyethylene stearates,
Poly (beta-benzyl-L-aspartate) -b- poly (ethylene oxide), Poly
(caprolactone) -b- poly (ethylene oxide)
6.
Hydrotropes
Urea, Nicotinamide, Sodium benzoate, Sodium salicylate,
Sodium acetate, Sodium-o-hydroxy benzoate, Sodium-p-hydroxy
benzoate, Sodium citrate
7.
Polyglycolized glycerides
Gelucire 44/14, Gelucire 50/13, Gelucire 62/05
8.
Acids
Citric acid, Succinic acid, Phosphoric acid
9.
Dendrimers
Starburst® polyamidoamine (PAMAM)
10.
Miscellaneous
Microcrystalline cellulose, Dicalcium phosphate, Silica gel,
Sodium chloride, Skimmed milk
-Cyclodextrins, Hydroxypropyl- -cyclodextrins
due to increase in surface area and hence
surface free energy [9].
Solid dispersions of norfloxacin with PEG
6000 in weight ratios of 10:90, 20:80, 30:70
and 50:50 were prepared by fusion method.
Solubility studies revealed no significant
increase in solubility of norfloxacin on
addition of PEG. Dissolution studies showed
maximum dissolution rate of drug with PEG
6000 in 30:70 and 20:80 weight ratios
establishing the effect and importance of
optimum weight fraction of polymer [33].
Solid dispersions of piroxicam were prepared
using polyvinylpyrrolidone K-30 in 1:0.5, 1:1,
1:2, 1:3, 1:5 and 1:6 ratio of drug to polymer
by solvent method. The dissolution of drug in
solid dispersion was dependent on drug to
e222p9
PVP ratio. The drug:PVP in 1:4 ratio, solid
dispersion gave highest dissolution rate of
about a 38-fold higher than that of pure drug
[12].
Carbamazepine/PEG 4000 and PEG 6000
solid dispersions were prepared by the
fusion method involving heating a physical
mixture of carbamazepine and either PEG
4000 or PEG 6000 in 1:2, 1:4, 1:6 and 1:8
drug/carrier ratios, to the liquid state.
Dissolution studies suggested that the
dissolution of carbamazepine from the solid
dispersion was neither related to the
molecular weight nor the weight fraction of
PEG. The enhancement in dissolution of
solid dispersion may be ascribed to complex
formation between carbamazepine and PEG
6000 during melting and a polymorphic
change during the preparation of solid
dispersion with carbamazepine crystalling in
Int J Health Res, June 2009; 2(2): 113
Saharan et al.
Dissolution Enhancement of Drugs
Table 2: Polymers and techniques employed for enhancing dissolution of poorly water soluble drugs
S/N.
Drug
Polymer
Technique
Mechanism of Dissolution Enhancement
Reference
1.
Glyburide
PEG 4000, PEG 6000 and
there mixtures
Solid dispersion by fusion and
solvent method
Increase in surface area and hence surface
free energy resulting in an increase in the
dissolution
(9)
2.
Norfloxacin
PEG 6000
Solid dispersion by fusion method
Solubilizing effect of PEG on the drug
(33)
3.
Piroxicam
PVP K-30
Solid dispersion by solvent method
Increase in drug wettability and the
presence of intermolecular hydrogen bonds
between piroxicam and PVP
(12)
4.
Carbamazepine
PEG 4000 and PEG 6000
Solid dispersion by fusion method
Complex formation between
carbamazepine and PEGs during melting
and a polymorphic change during the
preparation of solid dispersion, with
carbamazepine crystalling in a metastable
form of higher dissolution rate
(34)
5.
Piroxicam
PEG 4000
Solid dispersion by fusion and
solvent method
Increased wettability of drug, a local
solubilization effect of carrier at the diffusion
layer, formation of amorphous phase of
piroxicam and particle size reduction
resulted from interaction of drug and PEG
4000
(7)
6.
Flurbiprofen
Polyvinyl pyrrolidone (PVP),
Hydroxypropyl methylcellulose
(HPMC), Hydroxypropyl
cellulose (HPC), Poly ethylene
glycol (PEG) 6000
Solid dispersion by solvent method
Particle size reduction, improved
wettability of drug particle by the
carriers, solubilizing effect of
carrier and possible conversion
of crystalline drug into
amorphous form
(35)
7.
Glibenclamide
PEG 6000
Solid dispersion by fusion method
Solubilizing effect of PEG on the drug
(36)
8.
Roxithromycin
PEG 6000, HPMC K4M and
HPC
Solid dispersion by coprecipitate
method
Reduction of particle size of the drug and
surface tension lowering effect of carriers
resulting in wetting of hydrophobic
roxithromycin surface
(10)
9.
Gliclazide
PEG 4000 and PEG 6000
Solid dispersion by solvent method
Reduction of particle size resulting in
enhancement of surface area and increase
in drug wettability
(8)
e222p10
Int J Health Res, June 2009; 2(2): 114
Saharan et al.
Dissolution Enhancement of Drugs
Table 2: Polymers and techniques employed for enhancing dissolution of poorly water soluble drugs (continued)
S/N
Drug
Polymer
Technique
Mechanism of Dissolution Enhancement
Reference
10.
Albendazole
PEG 6000
Solid dispersion by fusion, solvent
and kneading method
Increased surface area for mass transfer,
thermodynamically enhanced dissolution of
a higher energy amorphous form from the
carrier, improved wetting and solubilization
(37)
11.
Rofecoxib
PEG 4000, PEG 6000, PVP
K25
Solid dispersion by hot-melt method
Formation of interstitial solid solutions
(2)
12.
Diclofenac
sodium,
Naproxen and
Piroxicam
Poly (2hydroxyethylmethacrylate)
(PHEMA)
Solid dispersion by solvent method
Conversion of crystalline drug into
amorphous form having higher aqueous
solubility
(38)
13.
Nifedipine,
Griseofulvin,
Indomethacin
PEG 6000-HPMC
Cogrinding
Interaction between drug and polymer
resulting in highly polar environment
(19)
14
Piroxicam
PEG 4600
Lipid based formulations
Solubilizing effect of PEG on the drug
(21)
15.
Carbamazepine
PEG 4000
Melt granulation
Solubilizing effect of PEG on the drug
(22)
16.
Griseofulvin
PEG 3350, Gelucire 44/14
Melt granulation
Higher hydrophilic character of the system
due to the presence of water-soluble
carriers and part of the drug dissolved in the
binder
(23)
17.
Naproxen,
Nifedipine,
Carbamazepine
HPMC USP Type 2208 (K3LV),
HPMC USP Type 2910 (E3LV
and E5LV)
Compaction process
Microenvironment surfactant effect where
by HPMC dissolution creates a local
surfactant concentration in the boundary
layer surrounding the drug particles,
providing a lower energy pathway for drug
dissolution
(24)
18.
Micronized
danazol
PVP K-15
Ultra-rapid freezing
Increase in solubility driving force, lowering
the heat of solution of the danazol, nanostructured amorphous drug domain, and
improved surface area.
(25)
19.
Prochlorperazine
maleate
HPMC
Coevaporates
Solubilization effect of carrier
(26)
20.
Piroxicam
Eudragit® L100 sodium salts
(EuLNa) and Eudragit® S100
sodium salts (EuSNa)
Fast-dissolving mucoadhesive
microparticulate delivery system
Mucoadhesive properties of carriers and
increase apparent drug solubility
(39)
e222p11
Int J Health Res, June 2009; 2(2): 115
Saharan et al.
a metastable form of higher dissolution rate
[34].
Solid dispersions of piroxicam in PEG 4000
at 1:1, 1:2 and 1:3 ratio of drug to polymer
were prepared by fusion and solvent method
with enhanced dissolution due to increased
wettability of drug, a local solubilization effect
of carrier at the diffusion layer, formation of
amorphous phase of piroxicam and particle
size reduction resulted from interaction of
drug and PEG 4000. Storage stability studies
at 25°C and 37° C for 10 weeks showed that
all dispersions were stable except that
uptake of water during storage may occur in
PEG system which leads to decrease of
piroxicam potency in piroxicam-PEG solid
dispersions [7].
Solid dispersions of flurbiprofen in PVP,
HPMC, HPC and PEG 6000 in 19:1 and 9:1
ratio of drug to carrier were prepared by
solvent method. Among these polymers PVP
gave highest enhancement (19-fold) in the
dissolution rate of flurbiprofen at 9:1 drug to
carrier ratio. The dissolution rate of
flurbiprofen with various polymer solutions
was in the descending order of PVP, HPMC,
PEG, and HPC at 9:1 ratio of drug to carrier.
As concentration of carrier in solid dispersion
was increased, the rate of dissolution was
also increased with PVP and HPMC while
decreased with HPC and PEG 6000 due to
aggregation of drug and carrier in solid
dispersion [35].
Solid dispersions of glibenclamide were
prepared using PEG 6000 by fusion method.
Dissolution studies revealed enhanced
dissolution of glibenclamide compared with
(R)
marketed daonil tablets (Hoechst) due to
improved wettability and dispersibility of drug
from solid dispersion [36]. Solid dispersions
of roxithromycin were prepared using PEG,
HPMC and HPC in 1:1, 1:3, and 1:5 ratio of
drug to polymer by coprecipitate method.
The dissolution rate of roxithromycin solid
dipersions was in the descending order of
PEG, HPMC, HPC and PEG showed highest
dissolution at 1:5 drug to PEG ratio.
Solubility of roxithromycin was directly
e222p12
Dissolution Enhancement of Drugs
proportional
to
the
increment
in
concentration of polymers from 0.5 to 3 %
polymer solution. Angle of repose and carr’s
index studies indicated fine nature and good
flow properties of the all formulations [10].
Solid dispersions of gliclazide were prepared
using PEG 4000 and PEG 6000 in 1:1, 1:3,
and 1:5 ratio of drug to polymer by solvent
method using chloroform as solvent. Drug:
carrier ratio of 1:5 was found to be optimum
for improving dissolution rate of gliclazide for
both polymer systems and PEG 6000 solid
dispersions showed faster dissolution than
PEG 4000 solid dispersions [8]. Solid
dispersions of albendazole were prepared
using PEG 6000 in 1:1, 1:3 and 1:5 ratio of
drug to polymer by fusion, solvent and
kneading
method.
Solid
dispersions
improved dissolution compared to physical
mixtures owing to increased surface area for
mass transfer, thermodynamically enhanced
dissolution of a higher energy amorphous
form from the carrier, improved wetting and
solubilization of the drug [37].
Solid dispersions of rofecoxib with PVP, PEG
4000 and PEG 6000 in 50%, 75% and 90%
w/w were prepared by hot-melt method. The
solubility efficiency of polymers was in the
order of PVP >> PEG 4000 > PEG 6000 due
to high amorphizing properties of PVP than
the
PEGs.
Significant
dissolution
improvement was observed at the highest
carrier amoumt i. e. 90% and was ascribed
to the formation of interstitial solid solutions
[2].
Solid molecular dispersion of diclofenac
sodium, naproxen and piroxicam using Poly
(2-hydroxyethylmethacrylate)
(PHEMA)
hydrogel as carrier were prepared by solvent
method using 90:10 ethanol:water for
diclofenac sodium, 100% ethanol for
naproxen, and 100% acetone for piroxicam.
The results showed threshold drug loading
level of about 30% in these solid dispersions,
above which amorphous to crystalline
transition may occur. The presence of
hydrogen bonding between drug and
polymer improves the compatibility between
Int J Health Res, June 2009; 2(2): 116
Saharan et al.
drug and polymer. Stability studies under
varying conditions of humidity (22-92 RH %)
showed transition from clear sample to an
opaque one on increasing humidity due to
increased mobility in the glassy PHEMA
matrix and solid dispersion remains in
amorphous form longer at low relative
humidity [38].
Coground mixtures of nifedipine, griseofulvin,
and indomethacin were prepared by
dispersing drug in the fused PEG 6000 and
then adding HPMC, MC, and PVA polymers
to the mixture. After cooling to room
temperature, the solidified mass was ground
using a ball mill. Then solvent like water,
methanol, ethanol, dichloromethane was
added to observe the effect of solvents and
further ground and dried to remove solvent.
The resultant mass was lightly pulverized to
pass through a 200 µm screen. Hydroxyl
groups in the water-soluble polymer
participate in the solubility enhancement and
some interactions between drug and the
polymer occurs during the cogrinding
process through the functional groups in a
small amount of water added (highly polar
environment). Solubility also increased in the
presence of organic solvents suggesting that
the pulverizing effect for drugs like nifedipine
also promote the drug- polymer interactions
[19].
Lipid based formulations of piroxicam were
prepared using 1,2-dimyristoyl-sn-glycero-3phosphatidylcholine (DMPC) phospholipids
alone in 1:1and 2:1 ratio of drug:DMPC and
a mixture of DMPC and PEG 4600 in 2:1:1
ratio. Dissolution studies showed highest
increase in drug release from combination of
lipid with PEG as compared to lipid alone
due to solubilizing effect of PEG on the drug
thus enhancing the dissolution rate. Storage
stability studies at 4°, 25° and 60°C revealed
stability of at least 6 months but beyond this
decrease in dissolution rates for formulations
containing PEG 4600 due to formation of a
crystalline mass upon storage for extended
period. Stabilizers like polyvinyl alcohols can
be added to increase storage stability of all
these preparations [21].
e222p13
Dissolution Enhancement of Drugs
Fast
release
rate
formulation
of
carbamazepine was prepared by melt
granulation technique using PEG 4000 as a
melt binder without using solvents or water.
Solid-state analysis indicated only a limited
reduction of the crystallinity of the drug and
no changes in its polymeric form. Granulates
showed a significant improvement of in vitro
drug
dissolution
behavior
but
the
intragranular addition of crospovidone (PVPCL) was found to be necessary to produce
tablets with a satisfactory disintegration time
and a remarkable increase of the drug
dissolution rate [22].
Granules of griseofulvin (2.5, 5.0%) were
prepared by melt granulation technique using
PEG 3350 and Gelucire 44/14 both in 20%
concentration as a melt binder and
transferred into hard gelatin capsules.
Dissolution rate of all prepared granules was
higher as compared to pure drug and its
physical mixtures. Granules having PEG as
binder
showed
large
dissolution
enhancement relative to both physical
mixtures and drug alone while granules
containing Gelucire 44/14 as binder showed
a significant dissolution enhancement as
compared to drug but slightly enhancement
compared to physical mixtures. The increase
in dissolution rate was ascribed to the highly
polar environment provided by water-soluble
carriers, part of the drug dissolved in the
binder and formation of monotectic mixture
of drug and PEG [23].
Compacts of naproxen, nifedipine, and
carbamazepine at a 1:1 polymer:drug weight
ratio were prepared using HPMC USP Type
2208 (K3LV), HPMC USP Type 2910 (E3LV
and E5LV) and methyl cellulose polymers by
slugging and roller compaction method. The
roller compaction and slugging methods
produced comparable rate and extent of drug
dissolution. This method require no solvent
or heat for formulation and is cost effective,
quicker, readily scalable at industrial scale
[24].
Int J Health Res, June 2009; 2(2): 117
Saharan et al.
Micronized danazol powders were prepared
by ultra rapid freezing using polyvinylpyrrolidone K-15 at a 1:2 ratio and 0.55% total
solid in either tert-butanol heated to 313 K or
acetonitrile solvent at room temperature with
enhanced dissolution of danazol. Use of
different solvents markly alters surface
morphology of powder. Danazol powder
produced by acetonitrile were spherical and
uniform in size as a result of the more rapid
and uniform cooling of the droplets relative to
tert-butanol. This process is viable and
robust for producing high surface area nanostructured powders for enhancing dissolution
[25].
Coevaporates of prochlorperazine maleate
(PCPM)
were
prepared
by
solvent
evaporation method using hydroxypropyl
methylcellulose phthalate as a carrier for
solubilization of drug in alkaline medium and
ethyl cellulose, hydroxypropyl cellulose for
controlling the dissolution rates of weak
basic drug PCPM. This method ensures
maximum bioavailability with controlled
release of drug from preparation [26].
Fast-dissolving mucoadhesive microparticles
for sublingual administration could be a
suitable alternative to fast-dissolving tablets
because the sublingual absorption can be
improved as a consequence of prolonging
residence time on the mucosa and reducing
the amount of swallowed drug. Lowswellable
mucoadhesive
methacrylic
®
copolymers, namely viz. Eudragit L sodium
salt and Eudragit® S sodium salt, were used
as effective carriers for the preparation of the
microparticles in ratio ranging from 15/85 to
85/15% (m/m) by spray drying. Their intrinsic
dissolution rates are faster than those of
most
commonly
used
mucoadhesive
polymers. Piroxicam was present in
amorphous form in all the prepared
microparticles which was anticipated due to
H-bond between the NH group of piroxicam
and a CO group of the copolymers. The best
delivery system made of piroxicam and
®
Eudragit L sodium salt in the ratio 70/30%
(m/m) was able to increase the apparent
e222p14
Dissolution Enhancement of Drugs
drug solubility by two times while maintaining
the desirable mucoadhesive properties [39].
Superdisintegrants
Dissolution of poorly water soluble drugs can
be markedly improved by use of
superdisintegrants
like sodium
starch
glycolate, croscarmellose sodium, crospovidone,
crosslinked
polyvinylpyrrolidone,
crosslinked alginic acid etc [40]. Some of the
recent studies utilizing superdisintegrants are
presented in Table 3.
Sodium starch glycolate swells 7- to 12-fold
in less than 30 sec. uniformly in all three
dimensions while croscarmellose swells 4- to
8-fold in less than 10 sec. in two dimensions
leaving fibre length similar. This indicates
that rate, force, and extent of swelling have
an important role in disintegrants that work
by swelling. Cross-linked PVP swells little
(due to absence of cationogenic groups in
the molecule) but returns to its original
boundaries quickly after compression.
Wicking or capillary action also is postulated
to be a major factor in the ability of crosslinked PVP to work as superdisintegrant [41].
Gellan gum and xanthan gum also have
extensive swelling properties for faster
disintegration. Calcium silicate is a highly
porous superdisintegrant which acts by
wicking action. Cross-linked alginic acid is a
hydrophilic colloidal substance with high
sorption capacity and acts by swelling or
wicking action [40].
Carrier particles of size from 50 to 1000
microns with cross-linked sodium (Ac-Di-Sol)
disintegrant in an optimum amount of 5 to
10% weight were prepared by granulating
liquid (ethanol) which did not dissolved the
disintegrant or caused the disintegrant to
swell [42]. These carrier particles were mixed
with micronized oxazepam for 50 hours to
obtain ordered mixture with surface area
ratios of 0.08, 0.57 and 1.5. With addition of
1% sodium lauryl sulphate in finely dispersed
form in mixture with the pharmaceutical
substance in the carrier, the dissolution rate
Int J Health Res, June 2009; 2(2): 118
Saharan et al.
Dissolution Enhancement of Drugs
Table 3: Superdisintegrants and techniques employed for enhancing dissolution of poorly water soluble drugs
S/N
Drug
Superdisintegrant
Technique
Mechanism of Dissolution Enhancement
Reference
1.
Naproxen
Cross-linked
polyvinylpyrrolidone
Drug loading on the surface of a
carrier
Higher surface area of the carrier and capillary
action of carrier
(51)
2.
Methlprednisolone,
Phenylbutazone
Sodium starch glycolate
Wet granulation
Swelling action of carrier
(44)
3.
Nifedipine
Croscarmellose sodium and
Crospovidone
Physical mixtures
Swelling action of croscarmellose sodium
and capillary action of crospovidone
(44)
4.
Oxazepam
Cross-linked sodium (Ac-DiSol)
Ordered mixing
Swelling action of carrier
(44)
5.
Furosemide
Crospovidone
Formation of coprecipitates by
solvent method
Capillary action of carrier
(45)
6.
Flurbiprofen
Sodium starch glycolate
(Primogel)
Dispersible tablets by wet
granulation
Swelling action of carrier
(46)
7.
Tenoxicam
Primogel, Ac-Di-Sol, and
Kollidon CL
Coprecipitation/Solvent
evaporation method
(47)
8.
Amorphous Ibuprofen
Cross-linked
polyvinylpyrrolidone
Solvent deposition
Swelling action of sodium starch glycolate,
croscarmellose sodium and
capillary action of crospovidone
Faster dissolution from amorphous ibuprofen,
drug deposition on carrier surfaces and
polymer swelling
9.
Aspirin
Sodium starch glycolate,
Croscarmellose sodium,
Crospovidone
Direct compression
Swelling action of sodium starch glycolate,
croscarmellose sodium and
capillary action of crospovidone
(49)
10.
Hydrochlorthiazide
Sodium starch glycolate,
Croscarmellose sodium
Direct compression
Swelling action of carriers
(49)
11.
Carbamazepine,
Nifedipine
Cross-linked
polyvinylpyrrolidone (Kollidon
CL-M)
By adsorption of drugs onto
high surface area carriers
Capillary action of carrier
(30)
12.
Chloroquine phosphate
Sodium starch glycolate,
Croscarmellose sodium and
Crospovidone
Wet granulation
Swelling action of sodium starch glycolate,
croscarmellose sodium and
capillary action of crospovidone
(52)
e222p15
(48)
Int J Health Res, June 2009; 2(2): 119
Saharan et al.
was independent of whether or not the water
solvent contains an additional surfactant [43]
and the dissolution rate increased so
markedly that about 90% of the composition
has passed into solution after two minutes.
Improvement of dissolution rate of nifedipine
by solid deposition on high percentages of
sodium starch glycolate and croscarmellose
sodium respectively, was explained by
deagglomeration of the micronized drug by
the superdisintegrant particles and solid
deposition upon the surface of strongly
swelling superdisintegrants which act as a
carrier. As an effect of swelling of the
superdisintegrants, the ‘wetted’ surface of
the carrier increases, this promotes
wettability and dispersibility of the particulate
system [44].
Coprecipitates of furosemide-crospovidone
were prepared by solvent method using
methanol with enhanced dissolution rate due
to association between the functional group
of furosemide and crospovidone at the
molecular level. The association was
probably between imino and sulfonylamide
group of furosemide and carboxyl group of
crospovidone [45].
Dispersible tablets of flurbiprofen were
formulated using pregelatinised starch,
microcrystalline cellulose and sodium starch
glycolate disintegrants alone and in different
combinations
containing
different
concentrations of disintegrants by wet
granulation method by employing starch
paste as binder. Among all, tablets
formulated by employing sodium starch
glycolate disintegrated rapidly and gave
faster dissolution of flurbiprofen [46].
Coprecipitates of tenoxicam with sodium
starch glycolate (Primogel), Ac-Di-Sol, and
cross-linked PVP (Kollidon CL) were
prepared by solvent evaporation method with
enhanced dissolution of tenoxicam. Kollidon
CL was found to be most effective
disintegrant of the three evaluated,
especially at 1:9 ratios [47].
e222p16
Dissolution Enhancement of Drugs
Drug/carrier
systems
of
amorphous
ibuprofen and cross-linked polyvinylpyrrolidone were prepared as physical mixes, and
drug was loaded onto the polymer by hot mix
and solvent deposition method. Increased
dissolution rate of ibuprofen were achieved
in the descending order of solvent
deposition, hot mixes, physical mixes. The
increased dissolution rate could be ascribed
to a combination of faster dissolution from
amorphous ibuprofen, drug deposition on
carrier surfaces and polymer swelling [48].
Tablets of aspirin were prepared by direct
compression technique using sodium starch
glycolate,
croscarmellose
sodium,
crospovidone as superdisintegrants. It was
found that the disintegration time was
comparable for tablets formulated with 1%
croscarmellose sodium, 2% crospovidone, or
5% sodium starch glycolate. However the
dissolution of aspirin from these tablets
varied in the following descending order
despite the closeness of their disintegration
times: croscarmellose sodium, sodium starch
glycolate, crospovidone [49]. Similarly
hydrochlorthiazide tablets were prepared by
direct compression method using sodium
starch glycolate, croscarmellose sodium as
superdisintegrants with enhanced dissolution
[50].
Carbamazepine
and
nifedipine
were
dissolved in methanol, polyethylene glycol,
2-pyrrolidone and adsorbed onto the surface
of
cross-linked
polyvinylpyrrolidone
(Kallidone). The solvent binding capacities
decreased in the order of methanol, PEG
4000, 2-pyrrolidone. Improved dissolution
rate of drugs was observed due to high
surface area of the carrier [30]. Similarly
increase in dissolution rate of naproxen by
loading
on
surface
of
cross-linked
polyvinylpyrrolidone was observed [51].
Tablets of chloroquine phosphate using
sodium starch glycolate, croscarmellose
sodium, and crospovidone as disintegrants in
2% w/w concentration were prepared by wet
granulation technique using intragranular
and extragranular methods. Disintegration
Int J Health Res, June 2009; 2(2): 120
Saharan et al.
and dissolution studies revealed intragranular method of application of disintegrants
more suitable which help the tablet to burst
into smaller particles as well as it may help to
dissolve the drug faster. Croscarmellose
sodium incorporated intragranular method
gave better results than extragranular
method as well as better than sodium starch
glycolate and crospovidone incorporated
extragranular and intragranular methods for
the chloroquine phosphate [52].
All above formulations prepared using
superdisintegrant indicates that use of
superdisintegrants is an easy alternate to
enhance dissolution of poorly water soluble
drugs without the addition of any other
excipient and changing the methodology of
preparation of specific drug. The only
disadvantage associated with the use of
superdisintegrants is its cost but overall cost
of formulation is less as compared to opting
specific measure to enhance dissolution.
Surfactants
Various surfactants like
Polyglycolized
glyceride (Labrasol), Tweens, Spans,
Polyoxyethylene stearates and synthetic
block copolymers like Poly (propylene
oxide)-poly (ethylene oxide) – poly (propylene oxide), an example of poloxamers
based
micelles,
Poly
(beta-benzyl-Laspartate) -b- poly (ethylene oxide), Poly
(caprolactone) -b- poly (ethylene oxide) etc
are used as carrier for dissolution
enhancement (Table 4). Improvement of
drug solubility by using the amphiphilic
surfactants is due to lowering surface tension
between drug and solvent, improvement of
wetting
characteristics
and
micellar
solubilization of the drugs. Micelles are
supramolecular
self
assemblies
of
macromolecules where unimers are held by
non-covalent interactions. The core of the
micelles solubilizes drugs whereas the
corona/shell allows for their suspension in
aqueous media [1].
Dissolution Enhancement of Drugs
Solid dispersions of albendazole using
poloxamer 407 as surfactant at 1:1, 1:3, 1:5
weight ratio were prepared and results
revealed a requirement of 0.75% as
minimum concentration of poloxamer for
solubility enhancement due to surface active
property and critical micellar concentration.
The albendazole-poloxamer melt (1:5 ratio)
showed 16.1 fold dissolution rate and 9.4
fold in dissolution efficiency as compared to
that of pure drug due to solubilization effect
in the diffusion layer [37].
Solid dispersions of rofecoxib were prepared
by hot-melt method using poloxamers
®
®
(Lutrol F127 and Lutrol F68) in 50%, 75%
and 90% w/w proportion. Enhancement in
solubility of system was observed due to
micellar solubilization and/or reduction of
activity coefficient of the drug through
reduction of hydrophobic interaction(s) and
higher dissolution was observed at high
(90%) carrier concentration [2].
Several liquisolid compacts were prepared
by dispersing piroxicam in tween 80 as liquid
to prepare liquid medication of the different
drug concentrations with different ratios of
drug:tween 80 ranging from 1:1 to 1:9 using
binary mixture of microcrystalline cellulose
(carrier powder)-silica (coating material) and
finally compressing. Results revealed
enhanced dissolution rate because drug is
already in solution in tween 80 and same
time drug is carried by powder particles of
the liquisolid vehicle. Thus, its release is
accelerated due to increased wettability and
surface availability to the dissolution medium
[31].
Conclusion
Numerous technological advancements have
been introduced for dissolution enhancement
of poorly water soluble drugs. Most of these
Int J Health Res, June 2009; 2(2): 121
Saharan et al.
Dissolution Enhancement of Drugs
Table 4: Surfactants and techniques employed for enhancing dissolution of poorly water soluble drugs
S/N
Drug
Surfactant
Technique
Mechanism of Dissolution
enhancement
Reference
1.
Albendazole
Poloxamer
407
Solid dispersion by
hot melt method
Surface active property of the
carrier, decreased crystallinity
of the product
(37)
e222p17
2.
Rofecoxib
Poloxamers
(Lutrol®
F127 and
Lutrol® F68)
Solid dispersion by
hot melt method
Micellar solubilization and/or
reduction of activity coefficient
of the drug through reduction
of hydrophobic interaction(s)
(2)
3.
Piroxicam
Labrasol
Semi-solid dispersion
Increase wetting and micellar
solubilization of the drug
(11)
4.
Piroxicam
Tween 80
Liquisolid compact
Increased wettability and
surface availability of the drug
to the dissolution medium
(31)
techniques utilize inert carriers which
improve
the
drug’s
physicochemical
properties like solubility, particle size, crystal
habit etc. Some of the carriers are especially
capable of forming highly water soluble
amorphous forms when the drugs are
dispersed in them or by size reduction (comicronization). Complexation of drug with
suitable carrier also alters the solubility and
dissolution characteristics due to extremely
high aqueous solubility of the carrier. The
solubility and dissolution rate improvements
are also expected due to co-solvency effect
and solubilisation effect of carriers in
aqueous vehicles. In a nutshell it could be
said
that
carrier
induced
physical
modifications are an important tool to a
formulation scientist in designing immediate
and fast release drug delivery systems. The
article continues as Part II [Int J Health Res,
Sept
2009;
2(3)]
which
describes
applications of cyclodextrins, carbohydrates,
hydrotropes,
polyglocolized
glycerides,
dendrimers, acids and other carriers in
enhancing dissolution of drugs.
2.
Ahuja N, Katare OP, Singh B. Studies on
dissolution enhancement and mathematical
modeling of drug release of a poorly water-soluble
drug using water-soluble carriers. Eur J Pharm
Biopharm 2007;65:26-38.
3.
Amidon GL, Lennernäs H, Shah VP, Crison JR. A
theoretical basis for a biopharmaceutic drug
classification: the correlation of in vitro drug product
dissolution and in vivo bioavailability. Pharm Res
1995;12:413-420.
4.
Chawdhary
KPR,
Vijayasrinivas
S.
Biopharmaceutical classification system. Indian
Pharmacist 2004;7-10.
5.
Jaiswal SB, Brahmankar DM. Biopharmaceutics
and pharmacokinetics. A Treatise; 1999; 25:165.
6.
Vadnere MK. Coprecipitates and melts. In:
Swarbrick J, Boylan, JC, editors. Encyclopaedia of
pharmaceutical technology 2nd ed. New York,
USA: Marcel Dekker, Inc.; 2002. 641-647 p.
7.
Pan RN, Chen JH, Chen RRL. Enhancement of
dissolution and bioavailability of piroxicam in solid
dispersion systems. Drug Dev Ind Pharm
2000;26:989-994.
8.
Reddy SJ, Gudsoorkar VR. Solid dispersions of
gliclazide. Indian Pharmacist Aug. 2005; IV:82-84.
9.
Betageri GV, Makarla KR. Enhancement of
dissolution of glyburide by solid dispersion and
lyophilization
techniques.
Int
J
Pharm
1995;126:155-160.
10. Patro S, Choudhary AA. Effect of some hydrophilic
polymers on dissolution rate of roxithromycin.
Indian J Pharm Sci 2005;67:334-341.
References
11. Karatas A, Nilufer Y, Baykara T. Improved solubility
and dissolution rate of piroxicam using gelucire
44/14 and labrasol. IL Farmaco 2005;60:777-782.
1.
12. Tantishaiyakul
V,
Kaewnopparat
N,
Ingkatawornwong S. Properties of solid dispersions
of piroxicam in polyvinylpyrrolidone K-30. Int J
Pharm 1996;143:59-66.
Savic R, Eisenberg A, Maysinger D. Block
e222p18
copolymer micelles as delivery vehicles of
hydrophobic drugs: Micelle-cell interactions. J Drug
Target 2006;14:343-355.
Int J Health Res, June 2009; 2(2): 122
Saharan et al.
Dissolution Enhancement of Drugs
13. Rouchotas C, Cassidy OE, Rowley G. Comparison
of surface modification and solid dispersion
techniques for drug dissolution. Int J Pharm
2000;195:1-6.
26. Nagarsenker
MS,
Garad
SD.
Physical
characterization and optimisation of dissolution
parameters
of
prochlorperazine
maleate
coevaporates. Int J Pharm 1998;160:251-255.
14. Parikh RK, Mansuri NS, Gohel MC, Sonlwala MM.
Dissolution enhancement of nimesulide using
complexation and salt formation techniques. Indian
drugs 2005;42:149-153.
27. Lantz, RJ, Schwartz JB. Tablets. In: Lieberman HA,
Lachman L, editors. Pharmaceutical dosage forms.
2nd ed. New York, USA: Marcel Dekker, Inc.; 2005.
15-20 p, 69 p.
15. Moyano JR, Blanco MJA, Gines JM, Giordano F.
Solid-state
characterization
and
dissolution
characteristics
of
gliclazide-beta-cyclodextrin
inclusion complexes. Int J Pharm 1997;148:211217.
28. Nystrom C, Westerberg M. The use of ordered
mixtures for improving the dissolution rate of low
solubility compounds. J Pharm Pharmacol
1986;38:161-165.
16. Doijad RC, Kanakal MM, Manvi FV. Studies on
piroxicam beta-cyclodextrin inclusion complexes.
Indian Pharmacist Jan 2007;VI:94-98.
17. Deshmukh SS, Potnis VV, Shelar DB, Mahaparale
PR. Studies on inclusion complexes of ziprasidone
hydrochloride
with
beta-cyclodextrin
and
hydroxypropyl-beta-cyclodextrin.
Indian
Drugs
2007;44:677-682.
18. Cavallari C, Abertini B, Rodriguez MLG, Rodriguez
L. Improved dissolution behaviour of steamgranulated piroxicam. Eur J Pharm Biopharm
2002;54:65-73.
19. Sugimoto M, Okagaki T, Narisawa S, Koida Y,
Nakajima
K.
Improvement
of
dissolution
characteristics and bioavailability of poorly watersoluble drug by novel cogrinding method using
water-soluble polymer. Int J Pharm 1998;160:1119.
20. Spence JK, Bhattachar SN, Wesley JA, Martin PJ,
Babu SR. Increased dissolution rate and
bioavailability
through
comicronization
with
microcrystalline cellulose. Drug Dev Ind Pharm
2005;10:451-460.
21. Prabhu S, Ortega M, Ma C. Novel lipid based
formulations enhancing the in vitro dissolution and
permeability characteristics of a poorly watersoluble model drug, piroxicam. Int J Pharm
2005;301:209-216.
22. Perissutti B, Rubessa F, Mariarosa M, Voinovich D.
Formulation design of carbamazepine fast-release
tablets prepared by melt granulation technique. Int
J Pharm 2003;256:53-63.
29. Alway B, Sangchantra R, Stewart PJ. Modelling the
dissolution of diazepam in lactose interactive
mixtures. Int J Pharm 1996;130:213-224.
30. Friedrich H, Fussnegger B, Kolter K, Bodmeier R.
Dissolution rate improvement of poorly watersoluble drugs obtained by adsorbing solutions of
drugs in hydrophilic solvents onto high surface area
carriers. Eur J Pharm Biopharm 2006;62:171-177.
31. Javadzadeh Y, Shadbad MRS, Jalali MB,
Nokhodchi A. Enhancement of dissolution rate of
piroxicam using liquisolid compacts. IL Farmaco
2005;60:361-365.
32. Jalali MB, Maleki N, Garjani A, Khandar AA.
Enhancement of dissolution rate and antiinflammatory effects of piroxicam using solvent
deposition technique. Drug Dev Ind Pharm
2002;28:681-686.
33. Guyot M, Fawaz F, Bildet J, Bonini F, Lagueny AM.
Physicochemical characterization and dissolution
of norfloxacin / cyclodextrin inclusion compounds
and PEG solid dispersions. Int J Pharm
1995;123:53-63.
34. El-Zein H, Riad L, El-Bary AA. Enhancement of
carbamazepine dissolution: in vitro and in vivo
evaluation. Int J Pharm 1998;168:209-220.
35. Ganesan V, Sivakumar SM, Kannadasan M.
Enhancement of dissolution rate of flurbiprofen.
Indian Pharmacist 2004;III:61-64.
36. Tashtoush BM, Al-Qashi ZS, Najib NM. Invitro and
invivo evaluation of glibenclamide in solid
dispersion systems. Drug Dev Ind Pharm
2004;30:601-607.
23. Yang D, Kulkarni R, Behme RJ, Kotiyan PN. Effect
of the melt granulation technique on the dissolution
characteristics of griseofulvin. Int J Pharm
2007;329:72-80.
37. Kalaiselvan R, Mohanta GP, Manna PK,
Manavalan R. Studies on mechanism of enhanced
dissolution of albendazole solid dispersions with
crystalline carriers. Indian J Pharm Sci 2006;599607.
24. Mitchell SA, Reynolds TD, Dasbach TP. A
compaction process to enhance dissolution of
poorly water-soluble drugs using hydrxypropyl
methylcellulose. Int J Pharm 2003;250:3-11.
38. Zahedi P, Lee PI. Solid molecular dispersions of
poorly water-soluble drugs in poly(2-hydroxyethyl
methacrylate) hydrogels. Eur J Pharm Biopharm
2007;65:320-328.
25. Overhoff KA, Engstrom JD, Chen B. Novel ultrarapid freezing particle engineering process for
enhancement of dissolution rates of poorly watersoluble drugs. Eur J Pharm Biopharm 2007;65:5767.
39. Cilurzo F, Selmin F, Minghetti P. Fast-dissolving
mucoadhesive microparticulate delivery system
containing piroxicam. Eur J Pharm Sci
2005;24:355-361.
e222p19
Int J Health Res, June 2009; 2(2): 123
Saharan et al.
40. Amin AF, Shah TJ, Dua R, Mishra R.
Superdisintegrants an economical alternative.
Pharma Focus Asia 2006;47-48.
41. Rudnic EM, Schwartz JD. Oral solid dosage forms.
In: Gennaro AR, Popovich NG, Marderosian, AHD,
et al., editors. Remington: The science and practice
of pharmacy. 20th ed. Philadelphia: Lippincott
Williams and Wilkins; 2000. 862 p.
42. Nystrom C, Westerberg M, Nilsson P. A
pharmaceutical composition. WO 89/06533 to
Kabivitrum AB, Stockholm (SE).
43. Nystrom C, Westerberg M. A pharmaceutical
composition for rapid release of the active
component comprising an orderred mixture and a
surfactant. WO 90/04962 to Kabivitrum AB,
Stockholm (SE).
44. Bolhuis GK, Zuurman K, Wierik GHP. Improvement
of dissolution of poorly soluble drugs by solid
deposition on a super disintegrant. II. the choice of
super disintegrants and effect of granulation. Eur J
Pharm Sci 1997;5:63-69.
45. Shin SC, Oh IJ, Lee YB, Choi HK, Choi JS.
Enhanced
dissolution
of
furosemide
by
coprecipitating or cogrinding with crospovidone. Int
J Pharm 1998;175:17-24.
46. Manvi FV, Hiremath BK, Kulkarni AS, Chalikwar
SS. Formulation and evaluation of dispersible
e222p20
Dissolution Enhancement of Drugs
tablets
of flurbiprofen.
2005;IV:68-71.
Indian
Pharmacist
47. Aly AM, Semreen M, Qato MK. Superdisintegrants
for solid dispersion To produce rapidly
disintegrating tenoxicam tablets via camphor
sublimation. Pharm Tech 2005;68-78.
48. Williams AC, Timmins P, Lu M, Forbes RT.
Disorders and dissolution enhancement: deposition
of ibuprofen on to insoluble polymers. Eur J Pharm
Sci 2005;26:288-294.
49. Zhao N, Augsburger LL. Functionality comparison
of 3 classes of superdisintegrants in promoting
aspirin tablet disintegration and dissolution. AAPS
PharmSciTech 2005;6:E 634-E 640.
50. Zhao N, Augsburger LL. The influence of swelling
capacity of superdisintegrants in different pH media
on the dissolution of hydrochlorthiazide from
directly compressed tablets. AAPS PharmaSciTech
2005;6:E 120-E 126.
51. Bettinetti G, Mura P. Dissolution properties of
naproxen in combination with polyvinylpyrrolidone.
Drug Dev Ind Pharm 1994;20:1353-1366.
52. Pandey VP, Reddy VK, Amarnath R. Formulation
and evaluation of chloroquine phosphate tablets
using some disintegrants. Indian Pharmacist
2007;VI:75-79.
Int J Health Res, June 2009; 2(2): 124